John Johnson

Affiliations

  • Director at Axogen Inc. (AXGN), 2024-09-05
  • Director at Verastem Inc. (VSTM), 2024-06-21
  • Director at Xeris Biopharma Holdings Inc. (XERS), 2024-06-05
  • Chief Executive Officer at Strongbridge Biopharma Plc (SBBP), 2021-10-06
  • Director at Portola Pharmaceuticals Inc (PTLA), 2020-07-02
  • Chief Executive Officer at Melinta Therapeutics Inc. W (MLNT), 2019-07-03
  • Director at Histogenics Corp (HSGX), 2018-06-19
  • Director at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
  • Director at Aveo Pharmaceuticals Inc (AVEO), 2018-02-05
  • Pres & Chief Executive Officer at Dendreon Corp (DNDN), 2014-07-08
  • Director at Tranzyme Inc (TZYM), 2012-08-09
  • Chief Executive Officer at Savient Pharmaceuticals Inc (SVNT), 2012-01-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CEMP $9.10 10,000 Director 10,000 2014-05-23 Filing
SVNT $2.30 5,000 Officer, Director 270,000 2011-11-21 Filing
SVNT $2.28 10,000 Officer, Director 265,000 2011-11-18 Filing
SVNT $2.36 1,000 Officer, Director 4,000 2011-11-18 Filing
DNDN $6.68 2,500 Director 12,943 2011-11-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MLNT $5.57 13,000 Officer, Director 37,400 2019-06-27 Filing
SVNT $2.30 17,650 Officer, Director 252,350 2012-01-03 Filing